Article Text

Download PDFPDF

S18 Activation of nociceptin orphanin FQ (N/OFQ) – N/OFQ peptide (NOP) receptor system plays a key immunomodulatory role in asthma
  1. R Singh1,
  2. N Sullo2,
  3. M Matteis2,
  4. G Spaziano2,
  5. J McDonald1,
  6. R Saunders1,
  7. L Woodman1,
  8. K Urbanek2,
  9. A DeAngelis2,
  10. R DePalma2,
  11. R Berair1,
  12. M Pancholi1,
  13. V Mistry1,
  14. P Bradding1,
  15. F Rossi2,
  16. R Guerrini3,
  17. G Calo3,
  18. B D'Agostino2,
  19. C E Brightling1,
  20. D G Lambert1
  1. 1University Of Leichester, Leichester, UK
  2. 2SecondUniversity of Naples, Naples, Italy
  3. 3University of Ferrara, Ferrara, Italy


Asthma is a complex heterogeneous disease characterised by variable airflow obstruction, bronchial hyper-responsiveness, airway inflammation and remodelling. The heptadecapeptide nociceptin/orphanin FQ (N/OFQ) is the endogenous ligand for the N/OFQ peptide (NOP) receptor, a non-opioid member of the opioid receptor family. The role of N/OFQ-NOP system in asthma is uncertain. We sought to evaluate N/OFQ-NOP expression in healthy and asthmatic human airway tissues and relate this to an established animal model of asthma.

NOP expression in human airway cells was investigated predominantly by qRT-PCR. The functional role of N/OFQ on human airway structural and immune cells was then interrogated using a range of functional assays including proliferation,migration,collagen gel contraction and wound healing. We further investigated the functional role of N/OFQ in vivo using ovalbumin-sensitised mice.

NOP expression was detected in human airway smooth muscle cells (HASM; mean?C? = 11 ± 0.7,n = 13), bronchial epithelial cells (HBEC;mean?C? = 10 ± 0.49,n = 12), lung mast cells (mean?C? = 7 ± 0.64,n = 5) and peripheral blood eosinophils (mean?C? = 10.4 ± 1.2,n = 16). N/OFQ inhibited chemoattractant-induced migration of mast cells and eosinophils (see Figure). N/OFQ stimulated significant HBEC wound closure with 49.62 ± 3.58% (p < 0.001, n = 8) of the wound area healed relative to the control (30.88 ± 4.13%, n = 8)18 h post-wound. Similarly N/OFQ significantly promoted HASM wound closure (p < 0.01). Our findings showed that SCF-stimulated IL-8 release (4.43 ± 0.69 fold over control, p < 0.01,n = 7) was significantly inhibited by N/OFQ (3.32 ± 0.56 fold over control, p < 0.01, n = 7). Ex vivo human studies demonstrate significantly (p < 0.01) increased endogenous N/OFQ in asthmatic airways relative (sputum N/OFQ:59.02 ± 2.57 pg/ml,n = 26) to healthy airways (sputum N/OFQ:44.69 ± 0.43,n = 10) and identifies eosinophils as a potential source for these. Pre-treatment with N/OFQ was shown to significantly reduce agonist-induced bronchial hyper-responsiveness using in vitro (p < 0.01) and in vivo models (p < 0.001). Ex vivo animal studies show that N/OFQ significantly inhibits release of inflammatory mediators including IL4, IL5, IL12, IL13 and inflammatory cell recruitment including mast cells and eosinophils within the airways. Further mucus hyper-secretion was also reduced following N/OFQ pre-treatment in these models.

Abstract S18 Figure 1.

N/OFQ inhibits chemoattractant-induced migration of lung mast cells and eosinophils. Migration of HMC-l cells (through an 8- µm pore-size transwell membrane) was enhanced following stimulation With SCF (p<0.01, n = 5), CXCL10 (p<0.001, n = 5) and TNF-α stimulated ASM s/n (p<0.001, n = 8) and this was significantly inhibited by N/OFQ (p<0.01). HLMC migration induced by SCF (p<0.001, n = 7) was significantly attenuated by N/OFQ (p<0.001, n = 7). Migration of peripheral blood eosinophils (n = 6) stimulated by epithelial conditioned media (p<0.01) was significantly inhibited by N/OFQ (p<0.01). Cell counts were performed by a blinded observer and data was represented as fold change over control in log (2) scale (mean ± SEM). Statistical analysis was performed by one-Way ANOVA With Bonferroni’s multiple comparison test. (*: p value vs control; #: p value vs different relevant stimulation).

This is the first study to perform a comprehensive and complementary in vivo and in vitro study of the expression and actions of the N/OFQ-NOP system in the airways and provide evidence for a role of NOP activation in the management of asthma.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.